Not on air · 2 of 3 networks checked
Meridian Life Science, Inc.
- meridianbioscience.com
- Biotechnology Research
- US
- 287 employees
Meridian Life Science, Inc.’s ads on LinkedIn, Meta and Google, recorded by adsrunning. Browse the latest here for free. Sign up free to see all 462. Watch Meridian Life Science, Inc. on any plan to get each new one in your feed.
Watchlist included in every plan
| Network | Status | Live ads | Nov 2025LinkedIn activity · 52 weeksNov 2026 | Checked | Next step |
|---|---|---|---|---|---|
| None recorded | 0 | Checked 3 Nov 2026 | See all 462 ads → | ||
| Meta | None recorded | 0 | No active ads recorded on the Meta Ad Library | Checked 23 Oct 2026 | Collect them with the API → |
| Not checked | — |
Meridian Life Science, Inc. has no live LinkedIn ads. Its Facebook page had no active ads on 23 Oct 2026, and we recorded 9 Google ads on 4 Oct 2026.
Latest ads
- LINKEDIN · IMAGESince 28 Oct 2026
Developing rapid flu or COVID-19 immunoassays? Spend less time screening reagents from scratch. AssayProven™ offers recommended components for Influenza A, Influenza B, and SARS-CoV-2, with lateral flow evaluation data to help your team choose candidates for early assay development.
- LINKEDIN · IMAGESince 23 Oct 2026
Respiratory season brings renewed focus to influenza and SARS-CoV-2 testing, making efficient reagent selection an important part of assay development. AssayProven™ provides recommended components for Influenza A, Influenza B and SARS-CoV-2 NP with relevant lateral flow evaluation data to help developers focus their screening earlier.
- LINKEDIN · IMAGESince 23 Oct 2026
Whether you’re developing assays for seasonal respiratory targets or other high-priority disease areas, broad reagent screening can consume valuable development time. AssayProven™ provides recommended immunoassay components supported by product-specific evaluation in CLIA, FIA or lateral flow formats, helping teams begin development with a more focused approach.
- LINKEDIN · IMAGESince 23 Oct 2026
Developing TORCH immunoassays that support women’s health? Spend less time screening reagents from scratch. AssayProven™ offers recommended components for Toxoplasma gondii IgG and Rubella IgG, with CLIA evaluation data from clinical serum samples to help your team make more informed choices during early assay development.
- LINKEDIN · IMAGESince 23 Oct 2026
Clinical matrix matters when selecting components for TORCH assay development, making relevant evaluation information valuable early in the process. AssayProven™ TSH components have been evaluated in an FIA format using clinical serum and whole-blood samples, providing developers with additional context to support early reagent selection.
- LINKEDIN · VIDEOSince 22 Oct 2026
Liquid reagents are the gold standard for many molecular workflows, but cold-chain shipping, high costs and limited shelf life can create significant challenges. In collaboration with Meridian Life Science, 4bases was able to overcome these limitations by leveraging our expertise in reagent stabilisation, enabling ambient-temperature shipping and storage of key reagents within their KaryoSolver™ workflow, while opening the door to future product innovation.
6 of 462 adsSign up to see every Meridian Life Science, Inc. ad, filter by format and date, and get alerts on new ones.
See all 462 adsWatch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.